Search

Start Over Keyword toxicity

  • Acetic acid activates distinct taste pathways in Drosophila to elicit opposing, state-dependent feeding responses

    Acetic acid activates distinct taste pathways in Drosophila to elicit opposing, state-dependent feeding responses
    Authors:Anita V. Devineni, Emory UniversityBei Sun, Columbia UniversityAnna Zhukovskaya, Columbia UniversityRichard Axel, Columbia University
    Date:2019
    Publisher:eLife Sciences Publications Ltd.
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Pentosan Polysulfate Maculopathy With 13 Years of Follow-up Imaging

    Pentosan Polysulfate Maculopathy With 13 Years of Follow-up Imaging
    Authors:Ashlyn M. Pinto ORCID logo , Dalhousie UniversityNieraj Jain, Emory UniversityR. Rishi Gupta, Dalhousie University
    Date:2024
    Publisher:SAGE
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • A Prospective Analysis of Quality of Life and Toxicity Outcomes in Treating Early Breast Cancer With Breast Conservation Therapy and Intraoperative Radiation Therapy

    A Prospective Analysis of Quality of Life and Toxicity Outcomes in Treating Early Breast Cancer With Breast Conservation Therapy and Intraoperative Radiation Therapy
    Authors:Michael Sosin, Medstar Georgetown University HospitalSurupa Sen Gupta, Medstar Georgetown University HospitalJessica S. Wang, Medstar Georgetown University HospitalCorinne D. Costellic, Medstar Georgetown University HospitalAiste Gulla, Medstar Georgetown University HospitalAlex J. Bartholomew, Medstar Georgetown University HospitalSuzanne C. O'Neill, Georgetown Lombardi Comprehensive Cancer CenterElizabeth Hechenbleikner, Emory UniversityBrian T. Collins, Medstar Georgetown University HospitalSonali Rudra, Medstar Georgetown University HospitalSean P. Collins, Medstar Georgetown University HospitalKrysta M. Chaldekas, Georgetown Lombardi Comprehensive Cancer CenterSulakshana Seevaratnam, Medstar Georgetown University HospitalRussell C. Langan, Medstar Georgetown University HospitalShawna C. Willey, Medstar Georgetown University HospitalEleni A. Tousimis, Medstar Georgetown University Hospital
    Date:2018
    Publisher:FRONTIERS MEDIA SA
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Challenges and Barriers to Adverse Event Reporting in Clinical Trials: A Children's Oncology Group Report

    Challenges and Barriers to Adverse Event Reporting in Clinical Trials: A Children's Oncology Group Report
    Authors:Tamara Miller, Emory UniversityMelissa Z Marx, University of ChicagoChristopher Henchen, Medical College of WisconsinNicholas P DeGroote, Childrens Healthcare AtlantaSally Jones, Washington UniversityJenny Weiland, University of Wisconsin, MadisonBeth Fisher, Childrens Healthcare AtlantaAdam J Esbenshade, Vanderbilt UniversityRichard Aplenc, Childrens Hospital of PhiladelphiaChristopher C Dvorak, University of California San FranciscoBrian T Fisher, University of California San Francisco
    Date:2022
    Publisher:LIPPINCOTT WILLIAMS & WILKINS
    Publication Version:Author Accepted Manuscript (After Peer Review)

  • FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases (FAST-01): Protocol for the First Prospective Feasibility Study

    FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases (FAST-01): Protocol for the First Prospective Feasibility Study
    Authors:Emily C Daugherty, University of CincinnatiAnthony Mascia, University of CincinnatiYong Zhang, University of CincinnatiEunsin Lee, University of CincinnatiZhiyan Xiao, University of CincinnatiMathieu Sertorio, University of CincinnatiJennifer Woo, Varian, A Siemens Healthineers CompanyClaire McCann, Varian, A Siemens Healthineers CompanyKenneth Russell, Varian, A Siemens Healthineers CompanyLisa Levine, Varian, A Siemens Healthineers CompanyRicky Sharma, Varian, A Siemens Healthineers CompanyDeepak Khuntia, Varian, A Siemens Healthineers CompanyJeffrey Bradley, Emory UniversityCharles B Simone, New York Proton CenterJohn Perentesis, Cincinnati Children's Hospital Medical CenterJohn Breneman, University of Cincinnati
    Date:2023
    Publisher:JMIR Publications
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Cross-Domain Text Mining to Predict Adverse Events from Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia

    Cross-Domain Text Mining to Predict Adverse Events from Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia
    Authors:Nidhi Mehra, Emory UniversityArmon Varmeziar, Emory UniversityXinyu Chen, Emory UniversityOlivia Kronick, Emory UniversityRachel Fisher, Emory UniversityVamsi Kota, Emory UniversityCassie Mitchell, Emory University
    Date:2022
    Publisher:MDPI
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Metabolomics as a Truly Translational Tool for Precision Medicine

    Metabolomics as a Truly Translational Tool for Precision Medicine
    Authors:Julian C Schmidt, Sovaris AerospaceBonnie V Dougherty, University of VirginiaRichard D Beger, US Food and Drug AdministrationDean Jones, Emory UniversityMichael A Schmidt, Sovaris AerospaceWilliam B Mattes, US Food and Drug Administration
    Date:2021
    Publisher:SAGE PUBLICATIONS INC
    Publication Version:Author Accepted Manuscript (After Peer Review)

  • A first-in-human Phase i trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma

    A first-in-human Phase i trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma
    Authors:John D Groot, University of California, San FranciscoMartina Ott, University of Texas MD Anderson Cancer CenterJun Wei, University of Texas MD Anderson Cancer CenterCynthia Kassab, University of Texas MD Anderson Cancer CenterDexing Fang, University of Texas MD Anderson Cancer CenterHinda Najem, Northwestern University Feinberg School of MedicineBarbara O'Brien, University of Texas MD Anderson Cancer CenterShiao-Pei Weathers, University of Texas MD Anderson Cancer CenterCarlos K Matsouka, University of Texas MD Anderson Cancer CenterNazanin K Majd, University of Texas MD Anderson Cancer CenterRebecca A Harrison, University of Texas MD Anderson Cancer CenterGregory N Fuller, University of Texas MD Anderson Cancer CenterJason T Huse, University of Texas MD Anderson Cancer CenterJames P Long, University of Texas MD Anderson Cancer CenterRaymond Sawaya, University of Texas MD Anderson Cancer CenterGanesh Rao, University of Texas MD Anderson Cancer CenterTobey MacDonald, Emory UniversityWaldemar Priebe, University of Texas MD Anderson Cancer CenterMichael Decuypere, Northwestern University Feinberg School of MedicineAmy B Heimberger, Northwestern University Feinberg School of Medicine
    Date:2022
    Publisher:Future Medicine Ltd
    Publication Version:Final Published Version
    License:Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

  • Full axillary lymph node dissection and increased breast epidermal thickness 1 year after radiation therapy for breast cancer

    Full axillary lymph node dissection and increased breast epidermal thickness 1 year after radiation therapy for breast cancer
    Authors:Jolinta Lin, Emory UniversityXiaofeng Yang, Emory UniversityMonica Serra, Emory UniversityAndrew Miller, Emory UniversityKaren Godette, Emory UniversityShannon Kahn, Emory UniversitySimone Henry, Emory UniversityGabrielle Brown, Emory UniversityTian Liu, Emory UniversityMylin Torres, Emory University
    Date:2019
    Publisher:Wiley
    Publication Version:Author Accepted Manuscript (After Peer Review)

  • Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

    Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Authors:Ethan Basch, University of North CarolinaClaus Becker, Deciphera Pharmaceuticals LLCLauren J. Rogak, Memorial Sloan Kettering Cancer CenterDeborah Schrag, Harvard UniversityBryce B. Reeve, Duke UniversityPatricia Spears, University of North CarolinaMary Lou Smith, Research Advocacy NetworkMrinal M. Gounder, Memorial Sloan Kettering Cancer CenterMichelle R. Mahoney, Mayo ClinicGary K. Schwartz, Columbia UniversityAntonia Bennett, University of North CarolinaTito R. Mendoza, University of Texas MD Anderson Cancer CenterCharles S. Cleeland, University of Texas MD Anderson Cancer CenterJeff A. Sloan, Mayo ClinicDeborah Bruner, Emory UniversityGisela Schwab, Exelixis, Inc.Thomas M. Atkinson, Mem Sloan Kettering Cancer CenterGita Thanarajasingam, Mayo ClinicMonica M. Bertagnolli, Brigham & Womens HospitalAmylou C. Dueck, Mayo Clinic
    Date:2020
    Publisher:SAGE Publications Ltd.
    Publication Version:Author Accepted Manuscript (After Peer Review)